News

Like
Share
Audax Private Equity
Like
Share
Audax Private Equity
Like
Share
Like
Share
Audax Private Equity
Like
Share
Charterhouse Capital Partners enters into exclusive negotiations for the sale of Cooper to CVC Capital Partners Fund VII and reinvestment in its next stage of growth

Charterhouse Capital Partners enters into exclusive negotiations for the sale of Cooper to CVC Capital Partners Fund VII and reinvestment in its next stage of growth

Charterhouse Capital Partners LLP has entered into exclusive negotiations for the sale of a majority stake in Cooper Consumer Health, a leading European independent over-the-counter (OTC) drug manufacturer and distributor, to CVC Fund VII. The transaction is subject to approval from relevant regulatory authorities and consultation with workers' councils.

Like
Share
Audax Private Equity
Like
Share
Like
Share
Audax Private Equity
Like
Share
Audax Private Equity
Like
Share